Industry Research Reports

Home > Reports > Chemical & Material > Valacyclovir API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Valacyclovir API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Chemical & Material

Published Date: 2025-01-16

Pages: 96 Pages

Report ld: 3565595

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global market for Valacyclovir API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

Valaciclovir(CAS：124832-26-4), also spelled valacyclovir, is an antiviral medication used to treat outbreaks of herpes simplex or herpes zoster (shingles).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Valacyclovir API, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Valacyclovir API by region & country, by Type, and by Application.

The Valacyclovir API market size, estimations, and forecasts are provided in terms of sales volume (Kg) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Valacyclovir API.

MARKET SEGMENTATION

By Company

Mylan
NEWEDGE Overseas
Aurore Life Sciences
Arch Pharmalabs
SMS Pharmaceuticals
Exemed PharmaceuticalsFDAWHO-GMP
Aurobindo Pharma LimitedFDAEDQMWHO-GMP
Piramal Pharma Solutions
Rajasthan Antibiotics
Vital Laboratories Private Limited

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Above 98 %
Above 99 %

Segment by Application

Tablets
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Valacyclovir API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Valacyclovir API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Valacyclovir API in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Valacyclovir API Product Introduction

1.2 Global Valacyclovir API Market Size Forecast

1.2.1 Global Valacyclovir API Sales Value (2020-2031)

1.2.2 Global Valacyclovir API Sales Volume (2020-2031)

1.2.3 Global Valacyclovir API Sales Price (2020-2031)

1.3 Valacyclovir API Market Trends & Drivers

1.3.1 Valacyclovir API Industry Trends

1.3.2 Valacyclovir API Market Drivers & Opportunity

1.3.3 Valacyclovir API Market Challenges

1.3.4 Valacyclovir API Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Valacyclovir API Players Revenue Ranking (2024)

2.2 Global Valacyclovir API Revenue by Company (2020-2025)

2.3 Global Valacyclovir API Players Sales Volume Ranking (2024)

2.4 Global Valacyclovir API Sales Volume by Company Players (2020-2025)

2.5 Global Valacyclovir API Average Price by Company (2020-2025)

2.6 Key Manufacturers Valacyclovir API Manufacturing Base and Headquarters

2.7 Key Manufacturers Valacyclovir API Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Valacyclovir API

2.9 Valacyclovir API Market Competitive Analysis

2.9.1 Valacyclovir API Market Concentration Rate (2020-2025)

2.9.2 Global 5 and 10 Largest Manufacturers by Valacyclovir API Revenue in 2024

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Valacyclovir API as of 2024)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Above 98 %

3.1.2 Above 99 %

3.2 Global Valacyclovir API Sales Value by Type

3.2.1 Global Valacyclovir API Sales Value by Type (2020 VS 2024 VS 2031)

3.2.2 Global Valacyclovir API Sales Value, by Type (2020-2031)

3.2.3 Global Valacyclovir API Sales Value, by Type (%) (2020-2031)

3.3 Global Valacyclovir API Sales Volume by Type

3.3.1 Global Valacyclovir API Sales Volume by Type (2020 VS 2024 VS 2031)

3.3.2 Global Valacyclovir API Sales Volume, by Type (2020-2031)

3.3.3 Global Valacyclovir API Sales Volume, by Type (%) (2020-2031)

3.4 Global Valacyclovir API Average Price by Type (2020-2031)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Tablets

4.1.2 Others

4.2 Global Valacyclovir API Sales Value by Application

4.2.1 Global Valacyclovir API Sales Value by Application (2020 VS 2024 VS 2031)

4.2.2 Global Valacyclovir API Sales Value, by Application (2020-2031)

4.2.3 Global Valacyclovir API Sales Value, by Application (%) (2020-2031)

4.3 Global Valacyclovir API Sales Volume by Application

4.3.1 Global Valacyclovir API Sales Volume by Application (2020 VS 2024 VS 2031)

4.3.2 Global Valacyclovir API Sales Volume, by Application (2020-2031)

4.3.3 Global Valacyclovir API Sales Volume, by Application (%) (2020-2031)

4.4 Global Valacyclovir API Average Price by Application (2020-2031)

5 Segmentation by Region

5.1 Global Valacyclovir API Sales Value by Region

5.1.1 Global Valacyclovir API Sales Value by Region: 2020 VS 2024 VS 2031

5.1.2 Global Valacyclovir API Sales Value by Region (2020-2025)

5.1.3 Global Valacyclovir API Sales Value by Region (2026-2031)

5.1.4 Global Valacyclovir API Sales Value by Region (%), (2020-2031)

5.2 Global Valacyclovir API Sales Volume by Region

5.2.1 Global Valacyclovir API Sales Volume by Region: 2020 VS 2024 VS 2031

5.2.2 Global Valacyclovir API Sales Volume by Region (2020-2025)

5.2.3 Global Valacyclovir API Sales Volume by Region (2026-2031)

5.2.4 Global Valacyclovir API Sales Volume by Region (%), (2020-2031)

5.3 Global Valacyclovir API Average Price by Region (2020-2031)

5.4 North America

5.4.1 North America Valacyclovir API Sales Value, 2020-2031

5.4.2 North America Valacyclovir API Sales Value by Country (%), 2024 VS 2031

5.5 Europe

5.5.1 Europe Valacyclovir API Sales Value, 2020-2031

5.5.2 Europe Valacyclovir API Sales Value by Country (%), 2024 VS 2031

5.6 Asia Pacific

5.6.1 Asia Pacific Valacyclovir API Sales Value, 2020-2031

5.6.2 Asia Pacific Valacyclovir API Sales Value by Region (%), 2024 VS 2031

5.7 South America

5.7.1 South America Valacyclovir API Sales Value, 2020-2031

5.7.2 South America Valacyclovir API Sales Value by Country (%), 2024 VS 2031

5.8 Middle East & Africa

5.8.1 Middle East & Africa Valacyclovir API Sales Value, 2020-2031

5.8.2 Middle East & Africa Valacyclovir API Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Valacyclovir API Sales Value Growth Trends, 2020 VS 2024 VS 2031

6.2 Key Countries/Regions Valacyclovir API Sales Value

6.2.1 Key Countries/Regions Valacyclovir API Sales Value, 2020-2031

6.2.2 Key Countries/Regions Valacyclovir API Sales Volume, 2020-2031

6.3 United States

6.3.1 United States Valacyclovir API Sales Value, 2020-2031

6.3.2 United States Valacyclovir API Sales Value by Type (%), 2024 VS 2031

6.3.3 United States Valacyclovir API Sales Value by Application, 2024 VS 2031

6.4 Europe

6.4.1 Europe Valacyclovir API Sales Value, 2020-2031

6.4.2 Europe Valacyclovir API Sales Value by Type (%), 2024 VS 2031

6.4.3 Europe Valacyclovir API Sales Value by Application, 2024 VS 2031

6.5 China

6.5.1 China Valacyclovir API Sales Value, 2020-2031

6.5.2 China Valacyclovir API Sales Value by Type (%), 2024 VS 2031

6.5.3 China Valacyclovir API Sales Value by Application, 2024 VS 2031

6.6 Japan

6.6.1 Japan Valacyclovir API Sales Value, 2020-2031

6.6.2 Japan Valacyclovir API Sales Value by Type (%), 2024 VS 2031

6.6.3 Japan Valacyclovir API Sales Value by Application, 2024 VS 2031

6.7 South Korea

6.7.1 South Korea Valacyclovir API Sales Value, 2020-2031

6.7.2 South Korea Valacyclovir API Sales Value by Type (%), 2024 VS 2031

6.7.3 South Korea Valacyclovir API Sales Value by Application, 2024 VS 2031

6.8 Southeast Asia

6.8.1 Southeast Asia Valacyclovir API Sales Value, 2020-2031

6.8.2 Southeast Asia Valacyclovir API Sales Value by Type (%), 2024 VS 2031

6.8.3 Southeast Asia Valacyclovir API Sales Value by Application, 2024 VS 2031

6.9 India

6.9.1 India Valacyclovir API Sales Value, 2020-2031

6.9.2 India Valacyclovir API Sales Value by Type (%), 2024 VS 2031

6.9.3 India Valacyclovir API Sales Value by Application, 2024 VS 2031

7 Company Profiles

7.1 Mylan

7.1.1 Mylan Company Information

7.1.2 Mylan Introduction and Business Overview

7.1.3 Mylan Valacyclovir API Sales, Revenue, Price and Gross Margin (2020-2025)

7.1.4 Mylan Valacyclovir API Product Offerings

7.1.5 Mylan Recent Development

7.2 NEWEDGE Overseas

7.2.1 NEWEDGE Overseas Company Information

7.2.2 NEWEDGE Overseas Introduction and Business Overview

7.2.3 NEWEDGE Overseas Valacyclovir API Sales, Revenue, Price and Gross Margin (2020-2025)

7.2.4 NEWEDGE Overseas Valacyclovir API Product Offerings

7.2.5 NEWEDGE Overseas Recent Development

7.3 Aurore Life Sciences

7.3.1 Aurore Life Sciences Company Information

7.3.2 Aurore Life Sciences Introduction and Business Overview

7.3.3 Aurore Life Sciences Valacyclovir API Sales, Revenue, Price and Gross Margin (2020-2025)

7.3.4 Aurore Life Sciences Valacyclovir API Product Offerings

7.3.5 Aurore Life Sciences Recent Development

7.4 Arch Pharmalabs

7.4.1 Arch Pharmalabs Company Information

7.4.2 Arch Pharmalabs Introduction and Business Overview

7.4.3 Arch Pharmalabs Valacyclovir API Sales, Revenue, Price and Gross Margin (2020-2025)

7.4.4 Arch Pharmalabs Valacyclovir API Product Offerings

7.4.5 Arch Pharmalabs Recent Development

7.5 SMS Pharmaceuticals

7.5.1 SMS Pharmaceuticals Company Information

7.5.2 SMS Pharmaceuticals Introduction and Business Overview

7.5.3 SMS Pharmaceuticals Valacyclovir API Sales, Revenue, Price and Gross Margin (2020-2025)

7.5.4 SMS Pharmaceuticals Valacyclovir API Product Offerings

7.5.5 SMS Pharmaceuticals Recent Development

7.6 Exemed PharmaceuticalsFDAWHO-GMP

7.6.1 Exemed PharmaceuticalsFDAWHO-GMP Company Information

7.6.2 Exemed PharmaceuticalsFDAWHO-GMP Introduction and Business Overview

7.6.3 Exemed PharmaceuticalsFDAWHO-GMP Valacyclovir API Sales, Revenue, Price and Gross Margin (2020-2025)

7.6.4 Exemed PharmaceuticalsFDAWHO-GMP Valacyclovir API Product Offerings

7.6.5 Exemed PharmaceuticalsFDAWHO-GMP Recent Development

7.7 Aurobindo Pharma LimitedFDAEDQMWHO-GMP

7.7.1 Aurobindo Pharma LimitedFDAEDQMWHO-GMP Company Information

7.7.2 Aurobindo Pharma LimitedFDAEDQMWHO-GMP Introduction and Business Overview

7.7.3 Aurobindo Pharma LimitedFDAEDQMWHO-GMP Valacyclovir API Sales, Revenue, Price and Gross Margin (2020-2025)

7.7.4 Aurobindo Pharma LimitedFDAEDQMWHO-GMP Valacyclovir API Product Offerings

7.7.5 Aurobindo Pharma LimitedFDAEDQMWHO-GMP Recent Development

7.8 Piramal Pharma Solutions

7.8.1 Piramal Pharma Solutions Company Information

7.8.2 Piramal Pharma Solutions Introduction and Business Overview

7.8.3 Piramal Pharma Solutions Valacyclovir API Sales, Revenue, Price and Gross Margin (2020-2025)

7.8.4 Piramal Pharma Solutions Valacyclovir API Product Offerings

7.8.5 Piramal Pharma Solutions Recent Development

7.9 Rajasthan Antibiotics

7.9.1 Rajasthan Antibiotics Company Information

7.9.2 Rajasthan Antibiotics Introduction and Business Overview

7.9.3 Rajasthan Antibiotics Valacyclovir API Sales, Revenue, Price and Gross Margin (2020-2025)

7.9.4 Rajasthan Antibiotics Valacyclovir API Product Offerings

7.9.5 Rajasthan Antibiotics Recent Development

7.10 Vital Laboratories Private Limited

7.10.1 Vital Laboratories Private Limited Company Information

7.10.2 Vital Laboratories Private Limited Introduction and Business Overview

7.10.3 Vital Laboratories Private Limited Valacyclovir API Sales, Revenue, Price and Gross Margin (2020-2025)

7.10.4 Vital Laboratories Private Limited Valacyclovir API Product Offerings

7.10.5 Vital Laboratories Private Limited Recent Development

8 Industry Chain Analysis

8.1 Valacyclovir API Industrial Chain

8.2 Valacyclovir API Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Valacyclovir API Sales Model

8.5.2 Sales Channel

8.5.3 Valacyclovir API Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Valacyclovir API Market Trends

Table 2. Valacyclovir API Market Drivers & Opportunity

Table 3. Valacyclovir API Market Challenges

Table 4. Valacyclovir API Market Restraints

Table 5. Global Valacyclovir API Revenue by Company (2020-2025) & (US$ Million)

Table 6. Global Valacyclovir API Revenue Market Share by Company (2020-2025)

Table 7. Global Valacyclovir API Sales Volume by Company (2020-2025) & (Kg)

Table 8. Global Valacyclovir API Sales Volume Market Share by Company (2020-2025)

Table 9. Global Market Valacyclovir API Price by Company (2020-2025) & (US$/Kg)

Table 10. Key Manufacturers Valacyclovir API Manufacturing Base and Headquarters

Table 11. Key Manufacturers Valacyclovir API Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Valacyclovir API

Table 13. Global Valacyclovir API Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Valacyclovir API as of 2024)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Valacyclovir API Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)

Table 17. Global Valacyclovir API Sales Value by Type (2020-2025) & (US$ Million)

Table 18. Global Valacyclovir API Sales Value by Type (2026-2031) & (US$ Million)

Table 19. Global Valacyclovir API Sales Market Share in Value by Type (2020-2025)

Table 20. Global Valacyclovir API Sales Market Share in Value by Type (2026-2031)

Table 21. Global Valacyclovir API Sales Volume by Type: 2020 VS 2024 VS 2031 (Kg)

Table 22. Global Valacyclovir API Sales Volume by Type (2020-2025) & (Kg)

Table 23. Global Valacyclovir API Sales Volume by Type (2026-2031) & (Kg)

Table 24. Global Valacyclovir API Sales Market Share in Volume by Type (2020-2025)

Table 25. Global Valacyclovir API Sales Market Share in Volume by Type (2026-2031)

Table 26. Global Valacyclovir API Price by Type (2020-2025) & (US$/Kg)

Table 27. Global Valacyclovir API Price by Type (2026-2031) & (US$/Kg)

Table 28. Global Valacyclovir API Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)

Table 29. Global Valacyclovir API Sales Value by Application (2020-2025) & (US$ Million)

Table 30. Global Valacyclovir API Sales Value by Application (2026-2031) & (US$ Million)

Table 31. Global Valacyclovir API Sales Market Share in Value by Application (2020-2025)

Table 32. Global Valacyclovir API Sales Market Share in Value by Application (2026-2031)

Table 33. Global Valacyclovir API Sales Volume by Application: 2020 VS 2024 VS 2031 (Kg)

Table 34. Global Valacyclovir API Sales Volume by Application (2020-2025) & (Kg)

Table 35. Global Valacyclovir API Sales Volume by Application (2026-2031) & (Kg)

Table 36. Global Valacyclovir API Sales Market Share in Volume by Application (2020-2025)

Table 37. Global Valacyclovir API Sales Market Share in Volume by Application (2026-2031)

Table 38. Global Valacyclovir API Price by Application (2020-2025) & (US$/Kg)

Table 39. Global Valacyclovir API Price by Application (2026-2031) & (US$/Kg)

Table 40. Global Valacyclovir API Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)

Table 41. Global Valacyclovir API Sales Value by Region (2020-2025) & (US$ Million)

Table 42. Global Valacyclovir API Sales Value by Region (2026-2031) & (US$ Million)

Table 43. Global Valacyclovir API Sales Value by Region (2020-2025) & (%)

Table 44. Global Valacyclovir API Sales Value by Region (2026-2031) & (%)

Table 45. Global Valacyclovir API Sales Volume by Region (Kg): 2020 VS 2024 VS 2031

Table 46. Global Valacyclovir API Sales Volume by Region (2020-2025) & (Kg)

Table 47. Global Valacyclovir API Sales Volume by Region (2026-2031) & (Kg)

Table 48. Global Valacyclovir API Sales Volume by Region (2020-2025) & (%)

Table 49. Global Valacyclovir API Sales Volume by Region (2026-2031) & (%)

Table 50. Global Valacyclovir API Average Price by Region (2020-2025) & (US$/Kg)

Table 51. Global Valacyclovir API Average Price by Region (2026-2031) & (US$/Kg)

Table 52. Key Countries/Regions Valacyclovir API Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031

Table 53. Key Countries/Regions Valacyclovir API Sales Value, (2020-2025) & (US$ Million)

Table 54. Key Countries/Regions Valacyclovir API Sales Value, (2026-2031) & (US$ Million)

Table 55. Key Countries/Regions Valacyclovir API Sales Volume, (2020-2025) & (Kg)

Table 56. Key Countries/Regions Valacyclovir API Sales Volume, (2026-2031) & (Kg)

Table 57. Mylan Company Information

Table 58. Mylan Introduction and Business Overview

Table 59. Mylan Valacyclovir API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 60. Mylan Valacyclovir API Product Offerings

Table 61. Mylan Recent Development

Table 62. NEWEDGE Overseas Company Information

Table 63. NEWEDGE Overseas Introduction and Business Overview

Table 64. NEWEDGE Overseas Valacyclovir API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 65. NEWEDGE Overseas Valacyclovir API Product Offerings

Table 66. NEWEDGE Overseas Recent Development

Table 67. Aurore Life Sciences Company Information

Table 68. Aurore Life Sciences Introduction and Business Overview

Table 69. Aurore Life Sciences Valacyclovir API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 70. Aurore Life Sciences Valacyclovir API Product Offerings

Table 71. Aurore Life Sciences Recent Development

Table 72. Arch Pharmalabs Company Information

Table 73. Arch Pharmalabs Introduction and Business Overview

Table 74. Arch Pharmalabs Valacyclovir API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 75. Arch Pharmalabs Valacyclovir API Product Offerings

Table 76. Arch Pharmalabs Recent Development

Table 77. SMS Pharmaceuticals Company Information

Table 78. SMS Pharmaceuticals Introduction and Business Overview

Table 79. SMS Pharmaceuticals Valacyclovir API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 80. SMS Pharmaceuticals Valacyclovir API Product Offerings

Table 81. SMS Pharmaceuticals Recent Development

Table 82. Exemed PharmaceuticalsFDAWHO-GMP Company Information

Table 83. Exemed PharmaceuticalsFDAWHO-GMP Introduction and Business Overview

Table 84. Exemed PharmaceuticalsFDAWHO-GMP Valacyclovir API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 85. Exemed PharmaceuticalsFDAWHO-GMP Valacyclovir API Product Offerings

Table 86. Exemed PharmaceuticalsFDAWHO-GMP Recent Development

Table 87. Aurobindo Pharma LimitedFDAEDQMWHO-GMP Company Information

Table 88. Aurobindo Pharma LimitedFDAEDQMWHO-GMP Introduction and Business Overview

Table 89. Aurobindo Pharma LimitedFDAEDQMWHO-GMP Valacyclovir API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 90. Aurobindo Pharma LimitedFDAEDQMWHO-GMP Valacyclovir API Product Offerings

Table 91. Aurobindo Pharma LimitedFDAEDQMWHO-GMP Recent Development

Table 92. Piramal Pharma Solutions Company Information

Table 93. Piramal Pharma Solutions Introduction and Business Overview

Table 94. Piramal Pharma Solutions Valacyclovir API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 95. Piramal Pharma Solutions Valacyclovir API Product Offerings

Table 96. Piramal Pharma Solutions Recent Development

Table 97. Rajasthan Antibiotics Company Information

Table 98. Rajasthan Antibiotics Introduction and Business Overview

Table 99. Rajasthan Antibiotics Valacyclovir API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 100. Rajasthan Antibiotics Valacyclovir API Product Offerings

Table 101. Rajasthan Antibiotics Recent Development

Table 102. Vital Laboratories Private Limited Company Information

Table 103. Vital Laboratories Private Limited Introduction and Business Overview

Table 104. Vital Laboratories Private Limited Valacyclovir API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 105. Vital Laboratories Private Limited Valacyclovir API Product Offerings

Table 106. Vital Laboratories Private Limited Recent Development

Table 107. Key Raw Materials Lists

Table 108. Raw Materials Key Suppliers Lists

Table 109. Valacyclovir API Downstream Customers

Table 110. Valacyclovir API Distributors List

Table 111. Research Programs/Design for This Report

Table 112. Key Data Information from Secondary Sources

Table 113. Key Data Information from Primary Sources

List of Figures

Figure 1. Valacyclovir API Product Picture

Figure 2. Global Valacyclovir API Sales Value, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Valacyclovir API Sales Value (2020-2031) & (US$ Million)

Figure 4. Global Valacyclovir API Sales Volume (2020-2031) & (Kg)

Figure 5. Global Valacyclovir API Sales Price (2020-2031) & (US$/Kg)

Figure 6. Valacyclovir API Report Years Considered

Figure 7. Global Valacyclovir API Players Revenue Ranking (2024) & (US$ Million)

Figure 8. Global Valacyclovir API Players Sales Volume Ranking (2024) & (Kg)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Valacyclovir API Revenue in 2024

Figure 10. Valacyclovir API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 11. Above 98 % Picture

Figure 12. Above 99 % Picture

Figure 13. Global Valacyclovir API Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)

Figure 14. Global Valacyclovir API Sales Value Market Share by Type, 2024 & 2031

Figure 15. Global Valacyclovir API Sales Volume by Type (2020 VS 2024 VS 2031) & (Kg)

Figure 16. Global Valacyclovir API Sales Volume Market Share by Type, 2024 & 2031

Figure 17. Global Valacyclovir API Price by Type (2020-2031) & (US$/Kg)

Figure 18. Product Picture of Tablets

Figure 19. Product Picture of Others

Figure 20. Global Valacyclovir API Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)

Figure 21. Global Valacyclovir API Sales Value Market Share by Application, 2024 & 2031

Figure 22. Global Valacyclovir API Sales Volume by Application (2020 VS 2024 VS 2031) & (Kg)

Figure 23. Global Valacyclovir API Sales Volume Market Share by Application, 2024 & 2031

Figure 24. Global Valacyclovir API Price by Application (2020-2031) & (US$/Kg)

Figure 25. North America Valacyclovir API Sales Value (2020-2031) & (US$ Million)

Figure 26. North America Valacyclovir API Sales Value by Country (%), 2024 VS 2031

Figure 27. Europe Valacyclovir API Sales Value, (2020-2031) & (US$ Million)

Figure 28. Europe Valacyclovir API Sales Value by Country (%), 2024 VS 2031

Figure 29. Asia Pacific Valacyclovir API Sales Value, (2020-2031) & (US$ Million)

Figure 30. Asia Pacific Valacyclovir API Sales Value by Region (%), 2024 VS 2031

Figure 31. South America Valacyclovir API Sales Value, (2020-2031) & (US$ Million)

Figure 32. South America Valacyclovir API Sales Value by Country (%), 2024 VS 2031

Figure 33. Middle East & Africa Valacyclovir API Sales Value, (2020-2031) & (US$ Million)

Figure 34. Middle East & Africa Valacyclovir API Sales Value by Country (%), 2024 VS 2031

Figure 35. Key Countries/Regions Valacyclovir API Sales Value (%), (2020-2031)

Figure 36. Key Countries/Regions Valacyclovir API Sales Volume (%), (2020-2031)

Figure 37. United States Valacyclovir API Sales Value, (2020-2031) & (US$ Million)

Figure 38. United States Valacyclovir API Sales Value by Type (%), 2024 VS 2031

Figure 39. United States Valacyclovir API Sales Value by Application (%), 2024 VS 2031

Figure 40. Europe Valacyclovir API Sales Value, (2020-2031) & (US$ Million)

Figure 41. Europe Valacyclovir API Sales Value by Type (%), 2024 VS 2031

Figure 42. Europe Valacyclovir API Sales Value by Application (%), 2024 VS 2031

Figure 43. China Valacyclovir API Sales Value, (2020-2031) & (US$ Million)

Figure 44. China Valacyclovir API Sales Value by Type (%), 2024 VS 2031

Figure 45. China Valacyclovir API Sales Value by Application (%), 2024 VS 2031

Figure 46. Japan Valacyclovir API Sales Value, (2020-2031) & (US$ Million)

Figure 47. Japan Valacyclovir API Sales Value by Type (%), 2024 VS 2031

Figure 48. Japan Valacyclovir API Sales Value by Application (%), 2024 VS 2031

Figure 49. South Korea Valacyclovir API Sales Value, (2020-2031) & (US$ Million)

Figure 50. South Korea Valacyclovir API Sales Value by Type (%), 2024 VS 2031

Figure 51. South Korea Valacyclovir API Sales Value by Application (%), 2024 VS 2031

Figure 52. Southeast Asia Valacyclovir API Sales Value, (2020-2031) & (US$ Million)

Figure 53. Southeast Asia Valacyclovir API Sales Value by Type (%), 2024 VS 2031

Figure 54. Southeast Asia Valacyclovir API Sales Value by Application (%), 2024 VS 2031

Figure 55. India Valacyclovir API Sales Value, (2020-2031) & (US$ Million)

Figure 56. India Valacyclovir API Sales Value by Type (%), 2024 VS 2031

Figure 57. India Valacyclovir API Sales Value by Application (%), 2024 VS 2031

Figure 58. Valacyclovir API Industrial Chain

Figure 59. Valacyclovir API Manufacturing Cost Structure

Figure 60. Channels of Distribution (Direct Sales, and Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Valacyclovir API market? zhanKai

The top companies in the global Valacyclovir API market are Mylan、NEWEDGE Overseas、Aurore Life Sciences.

Related Reports

Valacyclovir API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Valacyclovir API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-06-16
Pages: 135
USD 3950.00
(Single User License)
Global Valacyclovir API Market Research Report 2026
The global Valacyclovir API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-18
Pages: 126
USD 2900.00
(Single User License)
Global Valacyclovir API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Valacyclovir API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-11-09
Pages: 78
USD 4250.00
(Single User License)
Global Valacyclovir API Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Valacyclovir API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-09
Pages: 132
USD 4900.00
(Single User License)
Global Valacyclovir API Market Research Report 2025
The global market for Valacyclovir API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-16
Pages: 92
USD 2900.00
(Single User License)
Global Valacyclovir API Market Research Report 2024
Valaciclovir(CAS：124832-26-4), also spelled valacyclovir, is an antiviral medication used to treat outbreaks of herpes simplex or herpes zoster (shingles).
Published Date: 2024-02-07
Pages: 102
USD 2900.00
(Single User License)

Valacyclovir API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Valacyclovir API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-06-16
Pages: 135
USD 3950.00 (Single User License)
Global Valacyclovir API Market Research Report 2026
The global Valacyclovir API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-18
Pages: 126
USD 2900.00 (Single User License)
Global Valacyclovir API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Valacyclovir API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-09
Pages: 78
USD 4250.00 (Single User License)
Global Valacyclovir API Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Valacyclovir API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-09
Pages: 132
USD 4900.00 (Single User License)
Global Valacyclovir API Market Research Report 2025
The global market for Valacyclovir API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-16
Pages: 92
USD 2900.00 (Single User License)
Global Valacyclovir API Market Research Report 2024
Valaciclovir(CAS：124832-26-4), also spelled valacyclovir, is an antiviral medication used to treat outbreaks of herpes simplex or herpes zoster (shingles).
Published: 2024-02-07
Pages: 102
USD 2900.00 (Single User License)